Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
TP53 mutations predict decitabine-induced complete responses in patients with myelodysplastic syndromes. [electronic resource] by
- Chang, Chun-Kang
- Zhao, You-Shan
- Xu, Feng
- Guo, Juan
- Zhang, Zheng
- He, Qi
- Wu, Dong
- Wu, Ling-Yun
- Su, Ji-Ying
- Song, Lu-Xi
- Xiao, Chao
- Li, Xiao
Producer: 20170608
In:
British journal of haematology vol. 176
Availability: No items available.
|
|
|
9.
|
Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes. [electronic resource] by
- Xu, Feng
- Wu, Ling-Yun
- He, Qi
- Wu, Dong
- Zhang, Zheng
- Song, Lu-Xi
- Zhao, You-Shan
- Su, Ji-Ying
- Zhou, Li-Yu
- Guo, Juan
- Chang, Chun-Kang
- Li, Xiao
Producer: 20190305
In:
Scientific reports vol. 7
Availability: No items available.
|
|
|
10.
|
[Yield of CD34(+) cells in graft can be increased significantly by G-CSF used at appropriate time after chemotherapy for AutoPBSCT]. [electronic resource] by
- Xu, Li
- Chang, Chun-Kang
- Gan, Wei-Jin
- Su, Ji-Ying
- Zhang, Xi
- Wu, Lin-Yun
- Song, Lu-Xi
- He, Qi
- Zhou, Li-Yu
- Xiao, Chao
- Liu, Hong
- Li, Xiao
Producer: 20120119
In:
Zhongguo shi yan xue ye xue za zhi vol. 19
Availability: No items available.
|
|
|
11.
|
Increased PD-1/STAT1 ratio may account for the survival benefit in decitabine therapy for lower risk myelodysplastic syndrome. [electronic resource] by
- Zhang, Zheng
- Chang, Chun-Kang
- He, Qi
- Guo, Juan
- Tao, Ying
- Wu, Ling-Yun
- Xu, Feng
- Wu, Dong
- Zhou, Li-Yu
- Su, Ji-Ying
- Song, Lu-Xi
- Xiao, Chao
- Li, Xiao
Producer: 20171222
In:
Leukemia & lymphoma vol. 58
Availability: No items available.
|
|
|
12.
|
Distinct clinical and experimental characteristics in the patients younger than 60 years old with myelodysplastic syndromes. [electronic resource] by
- Li, Xiao
- Xiao, Zhi-jian
- Chang, Chun-kang
- Xu, Feng
- Wu, Ling-yun
- He, Qi
- Xu, Ze-feng
- Song, Lu-xi
- Zhang, Zheng
- Zhou, Li-yu
- Su, Ji-ying
- Zhang, Xi
- Guo, Juan
Producer: 20130910
In:
PloS one vol. 8
Availability: No items available.
|
|
|
13.
|
Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes. [electronic resource] by
- Zhang, Zheng
- He, Qi
- Tao, Ying
- Guo, Juan
- Xu, Feng
- Wu, Ling-Yun
- Zhao, You-Shan
- Wu, Dong
- Zhou, Li-Yu
- Su, Ji-Ying
- Song, Lu-Xi
- Xiao, Chao
- Li, Xiao
- Chang, Chun-Kang
Publication details: American journal of translational research 2017
In:
American journal of translational research vol. 9
Availability: No items available.
|
|
|
14.
|
Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes. [electronic resource] by
- Xu, Feng
- Li, Xiao
- Chang, Chun-Kang
- Guo, Juan
- Wu, Ling-Yun
- He, Qi
- Zhang, Zheng
- Zhu, Yang
- Gu, Shu-Chen
- Shi, Wen-Hui
- Song, Lu-Xi
- Su, Ji-Ying
- Zhou, Li-Yu
- Zhang, Xi
- Wu, Dong
Producer: 20141218
In:
PloS one vol. 9
Availability: No items available.
|
|
|
15.
|
Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes. [electronic resource] by
- Xu, Feng
- Wu, Ling-Yun
- Chang, Chun-Kang
- He, Qi
- Zhang, Zheng
- Liu, Li
- Shi, Wen-Hui
- Guo, Juan
- Zhu, Yang
- Zhao, You-Shan
- Gu, Shu-Cheng
- Fei, Cheng-Ming
- Wu, Dong
- Zhou, Li-Yu
- Su, Ji-Ying
- Song, Lu-Xi
- Xiao, Chao
- Li, Xiao
Producer: 20160524
In:
Nature communications vol. 6
Availability: No items available.
|